CELL AND GENE THERAPY LTD.Active
Key figures
Like most small UK companies, CELL AND GENE THERAPY LTD. does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Filed accounts2019/20–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Total assets | — | — | — | — | — |
| Total liabilities | 37,960 | 37,960 | 37,960 | 37,960 | 11,385 |
| Net assets / total equity | 7,203 | 7,203 | 7,203 | 7,203 | 11,385 |
| Average number of employees | 1 | 1 | 1 | 1 | 1 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: CELL AND GENE THERAPY LTD.
Company
CELL AND GENE THERAPY LTD. is a private limited company registered with Companies House under company number 09415326. It was incorporated on 30 Jan 2015. Its status is active. The registered office is in London (W1G). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files micro-entity accounts. Net assets were £11,385, up 58.1% on the previous year. The company had an average of 1 employee. Figures are available for 7 financial years (2019/20–2025/26).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Oct 2027. The next confirmation statement is due by 11 Jul 2027.